Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news


From To
Kenya to roll out child-friendly tuberculosis medicines nationwide

TB medicines specially adapted for children have been available since 2015, as a result of the UNITAID-funded STEP-TB project. In 2013 UNITAID committed 16.72 million dollars towards the implementation of the STEP-TB project, which brought together TB Alliance, and other partners to develop the first formulations of TB medicines that meets dosage guidelines set by the World Health Organization (WHO) in 2010.

27 September 2016
Global pledge to stamp out drug-resistant infections

The 193 countries of the United Nations sign a landmark declaration to rid the world of drug-resistant infections or superbugs.

21 September 2016
BBC Health
UK pledges £1.1bn to global aid fund against Aids, TB and malaria

Britain will contribute £1.1bn to a global aid fund to help fight Aids, tuberculosis and malaria, but will attach a set of “demanding” performance targets, Priti Patel has announced. The money will fund 40m bed nets to tackle malaria, provide enough antiretroviral therapy for 1.3 million people with HIV and support the treatment of 800,000 people with tuberculosis. A proportion of the investment will be used to leverage £100m from the private sector specifically to tackle malaria.

20 September 2016
The Guardian
Global Fund greenlights regional TB program for miners in Southern Africa

The Wits Health Consortium has been approved as the principal recipient on a new, $30 million regional grant to address the growing problem of tuberculosis among Southern Africa’s miners.

19 September 2016
Global Fund Observer
Ugandan experience shows TB detection can be successfully incorporated into community HIV testing campaigns

Community health campaigns provide an opportunity to detect previously undiagnosed cases of tuberculosis (TB), investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes.

16 September 2016
Michael Carter
WHO launches Target Regimen Profiles for TB treatment

Aimed at the pharmaceutical industry, research institutions, product development partnerships and donors, the new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

08 September 2016
World Health Organization
TB Can Persist in Lungs Despite Treatment

The findings show that TB bacteria may persist in the lungs even after patients have finished treatment and are free of clinical symptoms. Although it is unclear how this might affect the risk of disease relapse, the study results underscore the need for new diagnostic methods and improved TB treatment strategies, according to the researchers.

07 September 2016
National Institute of Allergy and Infectious Diseases
New insight into the progression of tuberculosis infection

A new study suggests it may be possible to predict which people infected with TB will develop the disease.

07 September 2016
Imperial College London
Underfunded tuberculosis programs often solely responsible for TB-HIV activities, report finds

While tuberculosis remains the number one killer of people living with HIV – with one in three HIV-related deaths attributable to tuberculosis – the burden to provide TB-HIV integrated services falls heavily on tuberculosis programs, not HIV programs, a report from Action finds.

06 September 2016
Science Speaks
Without Success in India, We'll Never Control Drug-Resistant Tuberculosis Anywhere

Two newly released studies from India make the global fight against antibiotic resistance and drug-resistant tuberculosis (TB) feel even more daunting. India is critical to the control of TB and other antibiotic resistance, as it is both the largest consumer of antibiotics in the world and has the highest burden of TB, affecting 2.2 million of its people each year, a quarter of the world total.

01 September 2016

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.